MetaCap

Jupiter Neurosciences (JUNS) vs KALA BIO (KALA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

KALA BIO is the larger company by market cap ($1.7 million vs $1.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

JUNS-56.51%KALA+651.39%
+1015%+451%-113%
Oct 7, 20261 yearNov 20, 2026
JUNS-56.67%KALA+820.38%
+864%+382%-101%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

JUNS versus KALA key metrics
MetricJUNSKALA
Share price$1.24$2.71
Market cap$1.63M$1.74M
1-day change-18.75%-10.28%
Forward P/E20.58—
EPS (TTM)$-22.53$-321.30
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$21.80K$0
Net income (latest FY)$-8.64M$-26.98M
Gross margin80.59%—
Operating margin-40873.19%—
Net margin-39662.77%—
52-week high$97.73$2,865.00
52-week low$1.20$2.65
Distance from 52-week high-98.74%-99.91%
Average volume69.86K52.52K
Shares outstanding1.32M644.66K
Employees56
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Jupiter Neurosciences

JUNS stock →

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About KALA BIO

KALA stock →

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

JUNS vs KALA FAQ

Which is bigger, Jupiter Neurosciences or KALA BIO?

KALA BIO (KALA) is larger, with a market capitalization of $1.74M compared with $1.63M for Jupiter Neurosciences (JUNS).

Are Jupiter Neurosciences and KALA BIO in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons